22 May 2013
Keywords: vicuron, reduce, costs, due, anidulaflungin, delay, pharmaceuticals
Article | 28 June 2004
Vicuron Pharmaceuticals of the USA has announced details of its plan to reduce operating expenses in light of the delay ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
31 May 2004
2 February 2004
© 2013 thepharmaletter.com